michael birrer, md, on the key takeaways from the ovarian plenary session in ovarian cancer
Published 5 years ago • 49 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
0:44
michael j. birrer, md, phd, on the role of maintenance therapy in newly diagnosed ovarian cancer
-
0:51
michael j. birrer, md, phd, considers the benefits of various parp inhibitors in ovarian cancer
-
1:01
michael j. birrer, md, phd, regarding brca status in newly diagnosed ovarian cancer
-
42:00
prospects for targeted therapy in ovarian cancer - by michael birrer, md, phd
-
1:18
michael birrer on predicting outcomes in ovarian cancer
-
1:58
dr. birrer on the approval process in ovarian cancer
-
2:34
dr. birrer on other targets in ovarian cancer
-
1:04
michael birrer discusses personalization of ovarian cancer care
-
15:14
ovarian cancer: signs, symptoms & screening
-
2:57
ovarian cancer: warning signs you should notice
-
26:49
mechanical options for preventing endometrial uterine cancer - 338 | menopause taylor
-
28:33
michael j. birrer md, phd: future of ovarian cancer treatment: personalized medicine
-
0:51
michael j. birrer, md, phd, elaborates on the outcomes from the forward i study
-
2:30
dr. birrer on parp inhibitors in ovarian cancer
-
3:16
dr. michael birrer on bevacizumab in ovarian cancers
-
1:49
dr. birrer on parp inhibitors in ovarian cancer
-
9:12
ovarian cancer explained (including subtypes)
-
1:34
dr. birrer discusses recurrent ovarian cancer treatment
-
3:14
current and emerging roles of parp inhibition in ovarian cancer
-
2:05
how important is collaboration in ovarian cancer research?
-
17:50
doc talk - episode 24: what to know about ovarian & endometrial cancers feat. kathrine croft, m.d.
-
3:54
carcinosarcoma centers of excellence discussion with michael birrer and diane redington